期刊
MICROORGANISMS
卷 11, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/microorganisms11102466
关键词
probiotics; non-alcoholic fatty liver disease; lactic acid bacteria; steatosis; beta-oxidation
类别
Lactiplantibacillus plantarum LP158, Lactobacillus helveticus HY7804, and Lacticaseibacillus paracasei LPC226 isolated from raw milk have been shown to alleviate non-alcoholic fatty acid disease (NAFLD). These strains inhibit fatty acid accumulation, modulate gene expression related to lipogenesis and beta-oxidation, and improve blood biochemistry markers and liver steatosis in a mouse model of NAFLD. HY7804 exhibits the strongest effects both in vitro and in vivo, suggesting its potential as a supplement for NAFLD treatment.
Here, we show that Lactiplantibacillus plantarum LP158 (LP158), Lactobacillus helveticus HY7804 (HY7804), and Lacticaseibacillus paracasei LPC226 (LPC226) isolated from raw milk alleviate non-alcoholic fatty acid disease (NAFLD) in a C57BL/6 mouse model. Lactic acid bacteria (LAB) were screened for their ability to inhibit fatty acid accumulation in palmitic acid (PA)-treated HepG2 cells, and three strains were selected based on the results. We also investigated hemolytic activity and antibiotic resistance of the three strains. LP158, HY7804, and LPC226 suppressed expression of mRNA encoding genes related to lipogenesis, and increased expression of genes related to beta-oxidation, in a PA-induced HepG2 cell model. Moreover, when LP158, HY7804, and LPC226 were administered at 10(9) CFU/kg/day for 8 weeks to mice with dietary-induced NAFLD, they all modulated blood biochemistry markers and reduced steatosis in liver tissue. Also, all three strains significantly reduced expression of mRNA encoding lipogenesis genes (Fasn, Acaca, and Srebp-1c) and inflammatory factors (Tnf alpha and Ccl-2) and fibrosis factors, and increased expression of a beta-oxidation gene (Acox1) in the liver. In particular, HY7804 showed the strongest effects both in vitro and in vivo. Therefore, HY7804, LP158, and LPC226 can be proposed as potential supplements that can improve NAFLD through anti-steatosis, anti-inflammatory, and anti-fibrotic effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据